title: Efficacy of danofloxacin in the therapy of experimental mycoplasmosis in chicks.
abstract: Specific pathogen free day-old chicks were inoculated with a virulent strain of Mycoplasma gallisepticum. Birds received either danofloxacin (50 ppm), tylosin (500 ppm) or no medication in the drinking water from 24 hours after infection for three days. The effects of medication on mortality, weight gain, serology, lesions and reisolation of M gallisepticum 21 days following infection were studied. Treatment with danofloxacin and tylosin significantly decreased mortality and increased weight gain compared with infected unmedicated birds. Twenty-one days after infection, M gallisepticum was isolated from 96 per cent of unmedicated birds compared with only 6 per cent of danofloxacin-treated and 40 per cent of tylosin-treated birds, and the percentage showing positive serological tests was reduced from 100 per cent of unmedicated birds to 0 per cent of danofloxacin-treated and 29 per cent of tylosin-treated birds. In both cases, the proportion of positive birds from the danofloxacin-treated group was significantly lower than that from the tylosin-treated group. The occurrence of air sac lesions was also significantly lower in danofloxacin-treated than in tylosin-treated birds.
authors.affiliation: Centre National d'Etudes Vétérinaires et Alimentàires, Laboratoire Central de Recherches Avicoles et Porcines, Ploufragan, France.
authors.forename: I
authors.initials: I
authors.lastname: Kempf
authors.forename: F
authors.initials: F
authors.lastname: Gesbert
authors.forename: M
authors.initials: M
authors.lastname: Guittet
authors.forename: G
authors.initials: G
authors.lastname: Bennejean
authors.forename: A C
authors.initials: AC
authors.lastname: Cooper
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D024841:Fluoroquinolones; D008297:Male; D009175:Mycoplasma Infections / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D011201:Poultry Diseases / Q000188:drug therapy* / Q000401:mortality; D015363:Quinolones / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D015645:Tylosin / Q000627:therapeutic use; D015430:Weight Gain
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C068581:danofloxacin; D015645:Tylosin